Rapa-Np treatment reduced the levels of p21CIP1 in treated TSC2−/− AML organoid xenografts, compared to nontreated ones, while simultaneously triggering CASP3 cleavage, by Day 7 (Fig. 7d). The gene discussed is CDKN1A; the disease is acute myeloid leukemia.